A chemotherapy drug used to fight bone-marrow cancer also has the potential to treat and prevent potentially deadly heart failure, a powerful new drug-screening tool developed at UVA Health suggests.
Research from a collaborative team of biomedical engineers, physicians and scientists could enable significant advances for the 40,000 pediatric congenital heart disease patients (CHD) born each year.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback